HALO
Halozyme Therapeutics, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #665
- Final score
- 42.98
- Years on list
- 1
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- HALO· Halozyme Therapeutics, Inc.
- IONS· Ionis Pharmaceuticals, Inc.
- RPRX· Royalty Pharma Plc
Figure 01 · Side-by-side summary
The headline numbers
IONS
Ionis Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #649
- Final score
- 43.60
- Years on list
- 6
↗ Climbed 270 since 2020
RPRX
Royalty Pharma PlcPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #672
- Final score
- 42.76
- Years on list
- 5
↘ Down 321 since 2021
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | HALO | IONS | RPRX |
|---|---|---|---|
| Climate Change | 45.8 | 47.7 | 41.2 |
| Employee Relations | 39.5 | 35.5 | 44.0 |
| Environment | 72.3 | 48.4 | 31.2 |
| Stakeholders & Society | 24.3 | 58.4 | 45.3 |
| Human Rights | 15.6 | 16.8 | 45.4 |
| Governance | 39.3 | 44.6 | 42.6 |
| Performance Rating | 54.1 | 57.7 | 79.4 |